INSM
Price
$145.38
Change
+$0.35 (+0.24%)
Updated
Sep 23 closing price
Capitalization
30.73B
29 days until earnings call
ONCO
Price
$2.99
Change
-$0.07 (-2.29%)
Updated
Sep 23 closing price
Capitalization
4.62M
50 days until earnings call
Interact to see
Advertisement

INSM vs ONCO

Header iconINSM vs ONCO Comparison
Open Charts INSM vs ONCOBanner chart's image
Insmed
Price$145.38
Change+$0.35 (+0.24%)
Volume$1.61M
Capitalization30.73B
Onconetix
Price$2.99
Change-$0.07 (-2.29%)
Volume$90.23K
Capitalization4.62M
INSM vs ONCO Comparison Chart in %
Loading...
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONCO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INSM vs. ONCO commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INSM is a Hold and ONCO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (INSM: $145.38 vs. ONCO: $2.99)
Brand notoriety: INSM and ONCO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INSM: 64% vs. ONCO: 12%
Market capitalization -- INSM: $30.73B vs. ONCO: $4.62M
INSM [@Biotechnology] is valued at $30.73B. ONCO’s [@Biotechnology] market capitalization is $4.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INSM’s FA Score shows that 1 FA rating(s) are green whileONCO’s FA Score has 1 green FA rating(s).

  • INSM’s FA Score: 1 green, 4 red.
  • ONCO’s FA Score: 1 green, 4 red.
According to our system of comparison, ONCO is a better buy in the long-term than INSM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INSM’s TA Score shows that 2 TA indicator(s) are bullish while ONCO’s TA Score has 3 bullish TA indicator(s).

  • INSM’s TA Score: 2 bullish, 6 bearish.
  • ONCO’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, ONCO is a better buy in the short-term than INSM.

Price Growth

INSM (@Biotechnology) experienced а +0.44% price change this week, while ONCO (@Biotechnology) price change was -8.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.75%. For the same industry, the average monthly price growth was +7.78%, and the average quarterly price growth was +47.65%.

Reported Earning Dates

INSM is expected to report earnings on Oct 23, 2025.

ONCO is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Biotechnology (+2.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INSM($30.7B) has a higher market cap than ONCO($4.62M). INSM YTD gains are higher at: 110.574 vs. ONCO (-94.416). ONCO has higher annual earnings (EBITDA): -43.75M vs. INSM (-938.1M). INSM has more cash in the bank: 1.86B vs. ONCO (284K). ONCO has less debt than INSM: ONCO (8.75M) vs INSM (576M). INSM has higher revenues than ONCO: INSM (398M) vs ONCO (1.33M).
INSMONCOINSM / ONCO
Capitalization30.7B4.62M664,215%
EBITDA-938.1M-43.75M2,144%
Gain YTD110.574-94.416-117%
P/E RatioN/A0.00-
Revenue398M1.33M29,992%
Total Cash1.86B284K653,873%
Total Debt576M8.75M6,581%
FUNDAMENTALS RATINGS
INSM: Fundamental Ratings
INSM
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
5
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
5

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INSMONCO
RSI
ODDS (%)
Bearish Trend 1 day ago
73%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bearish Trend 1 day ago
62%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 14 days ago
75%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONCO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IJJ129.960.16
+0.12%
iShares S&P Mid-Cap 400 Value ETF
IWMY23.39-0.01
-0.04%
Defiance R2000 Target 30 Income ETF
ESUM27.17-0.13
-0.47%
Eventide Us Market ETF
NKX12.52-0.08
-0.63%
Nuveen California AMT-Free Quality Municipal Income Fund
NERD28.03-0.26
-0.92%
Roundhill Video Games ETF

INSM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INSM has been closely correlated with THAR. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if INSM jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSM
1D Price
Change %
INSM100%
+0.24%
THAR - INSM
76%
Closely correlated
-3.09%
NWPHF - INSM
49%
Loosely correlated
N/A
CARM - INSM
46%
Loosely correlated
-3.47%
NUVL - INSM
45%
Loosely correlated
+2.76%
ROIV - INSM
42%
Loosely correlated
-1.34%
More

ONCO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONCO has been loosely correlated with OPORF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ONCO jumps, then OPORF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONCO
1D Price
Change %
ONCO100%
-2.29%
OPORF - ONCO
47%
Loosely correlated
N/A
PCSA - ONCO
34%
Loosely correlated
+8.45%
INSM - ONCO
30%
Poorly correlated
+0.24%
EVAX - ONCO
30%
Poorly correlated
-0.98%
APM - ONCO
27%
Poorly correlated
+0.57%
More